Virtual Library

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    State of art of TMB testing

    • Type: Specialty session
    • Presentations: 6
    • Coordinates: 4/11/2019, 11:00 - 12:30, Room W
  • +

    The future of I-O in advanced NSCLC

    • Type: Specialty session
    • Presentations: 6
    • Coordinates: 4/11/2019, 11:00 - 12:30, Room A
  • +

    Lunch & Poster Display session

    • Type: Poster Display session
    • Presentations: 170
    • Coordinates: 4/11/2019, 12:30 - 13:00, Hall 1
    • +

      3P - Notable variation of molecular testing in metastatic lung cancer in the Netherlands

      12:30 - 12:30  |  Presenter: Chantal Epskamp-Kuijpers

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      4P - Correlation between folate receptor alpha (FRα) expression and clinicopathological features in lung adenocarcinoma

      12:30 - 12:30  |  Presenter: Nobumasa Tamura

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      5P - The circular RNA circXPO1 promotes tumor growth in lung adenocarcinoma

      12:30 - 12:30  |  Presenter: Qi Huang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      6P - Correlation of epidermal growth factor receptor mutation status in plasma and tissue samples of patients with lung cancer

      12:30 - 12:30  |  Presenter: Choonhee Son

      • Abstract

      Loading...

    • +

      7P - Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models

      12:30 - 12:30  |  Presenter: Uri Weinberg

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      8P - Role of chemokines in resectable non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: Marie Drosslerová

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      9P - Clinical validation of an NGS-based assay for detecting multiple genomic alterations in Chinese patients with non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Huijuan Ge

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      10P - The prevalence and prognostic significance of JAK2 mutation subtypes in non-small cell lung cancer from Chinese populations

      12:30 - 12:30  |  Presenter: Wenxian Wang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      11P - Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells

      12:30 - 12:30  |  Presenter: lijun Liang

      • Abstract

      Loading...

    • +

      12P - Clinicopathologic characteristics of patients with TP63 mutations in Chinese non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Quxia Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      13P - The micro-environmental cross talk between mast cells and lung cancer cells through cell-to-cell contact

      12:30 - 12:30  |  Presenter: Rachel Shemesh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      14P - The characteristics of MET exon 14 skipping mutations in Chinese non-small cell lung cancer: A retrospective analysis

      12:30 - 12:30  |  Presenter: Youcai Zhu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      15P - TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor

      12:30 - 12:30  |  Presenter: Juan Felipe Cordoba Ortega

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      17P - REDOXI-miRNA of Keap1/Nrf2 axis in lung tumors

      12:30 - 12:30  |  Presenter: Federico Pio Fabrizio

      • Abstract

      Loading...

    • +

      18P - Immunohistochemical expression of PD-L1 in early and late stage non-small cell lung cancer: Correlation with clinicopathological and molecular features

      12:30 - 12:30  |  Presenter: Eleni Kokkotou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      19P - FOXP3Δ3, the major isoform of FOXP3, promotes proliferation, migration, and invasion in non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Hao JIA

      • Abstract

      Loading...

    • +

      20P - Atypical hyperplasia of bronchial epithelial cells induced by chronic exposure to PM 2.5 in mice

      12:30 - 12:30  |  Presenter: Tian Fang Hou

      • Abstract

      Loading...

    • +

      22P - Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

      12:30 - 12:30  |  Presenter: Daphne Dumoulin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      23P - Immunosenescence (iSenescence) correlates with progression (PD) to PD-(L)1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell lung cancer (aNSCLC) patients (pts)

      12:30 - 12:30  |  Presenter: Roberto Ferrara

      • Abstract

      Loading...

    • +

      24P - A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation

      12:30 - 12:30  |  Presenter: Paolo Manca

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      25P - Lung tumorspheres as a drug screening platform against cancer stem cells

      12:30 - 12:30  |  Presenter: Alejandro Herreros Pomares

      • Abstract

      Loading...

    • +

      26P - Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy

      12:30 - 12:30  |  Presenter: Laura Bonanno

      • Abstract

      Loading...

    • +

      27P - Comparison of three different gene panels for determination of tumor mutational burden by next generation sequencing

      12:30 - 12:30  |  Presenter: Roberto Pappesch

      • Abstract

      Loading...

    • +

      28P - Applicability of ctDNA at diagnosis and during the monitoring of EGFR-mutated patients

      12:30 - 12:30  |  Presenter: Silvia Calabuig Fariñas

      • Abstract

      Loading...

    • +

      29P - Pretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)

      12:30 - 12:30  |  Presenter: Oscar Jose Juan Vidal

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      30P - Prognostic significance of IGF-1 signaling pathway in patients with advanced non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Ioannis Kotsantis

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      31P - Do two lungs form an integrated immune system? Learning from BALF examination in lung cancer

      12:30 - 12:30  |  Presenter: Joanna Domagala-Kulawik

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      32P - Exosomes in NSCLC: Analysis of its cargo as a source of biomarkers

      12:30 - 12:30  |  Presenter: Elena Durendez-Saez

      • Abstract

      Loading...

    • +

      33P - Prognostic value of CD8-positive tumor stroma-infiltrating lymphocytes and PD-L1 positive tumor cells at initial biopsy in patients with locally advanced NSCLC treated with chemoradiotherapy

      12:30 - 12:30  |  Presenter: Kathrin Gennen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      34P - Impacts of HDAC2 inhibition on lung cancer treatment

      12:30 - 12:30  |  Presenter: Yao-Tsung Yeh

      • Abstract

      Loading...

    • +

      35P - Clinicopathological characteristics with genetic profiling and prognostic analysis of primary lymphoepithelioma-like carcinoma in Chinese south-eastern population

      12:30 - 12:30  |  Presenter: YInchen Shen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      36P - Can a BALF profile distinguish hot vs cold lung tumors?

      12:30 - 12:30  |  Presenter: Joanna Domagala-Kulawik

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      37P - Genetic variation of lymphotoxin beta receptor (LTβR) rs10849448 (A/G) is associated with risk for lung cancer and metastatic spread to adrenals

      12:30 - 12:30  |  Presenter: Foteinos-Ioannis D. Dimitrakopoulos

      • Abstract

      Loading...

    • +

      38P - Hedgehog pathway activation might mediate pemetrexed resistance in NSCLC cells

      12:30 - 12:30  |  Presenter: Yichao Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      39P - High dose apatinib in the reversal of immunosuppressive tumor microenvironment for irradiation therapy in lung carcinoma

      12:30 - 12:30  |  Presenter: lijun Liang

      • Abstract

      Loading...

    • +

      40P - The metabolic phenotypes of non-small cell lung cancer cells in association with clinical treatment strategies

      12:30 - 12:30  |  Presenter: Ting-Chun Kuo

      • Abstract

      Loading...

    • +

      41P - Diagnostic accuracy of droplet digital PCR (ddPCR) and amplification refractory mutation system PCR (ARMS-PCR) for detecting EGFR mutation in cell-free DNA of advanced lung cancer: A meta-analysis

      12:30 - 12:30  |  Presenter: Caichen Li

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      44P - Temporal trends in treatment (Tx) and overall survival (OS) among patients (pts) with incident NSCLC in the UK: A real-oncology database analysis from the I-O Optimise initiative

      12:30 - 12:30  |  Presenter: Michael Snee

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      45P - Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

      12:30 - 12:30  |  Presenter: Marta Alexandra Silva Soares

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      46P - Evolution of overall survival (OS) in patients (pts) with incident NSCLC in Denmark and Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

      12:30 - 12:30  |  Presenter: Jens Benn Sørensen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      47P - Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

      12:30 - 12:30  |  Presenter: Simon Ekman

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      48P - Education and lung cancer: A Mendelian randomisation study

      12:30 - 12:30  |  Presenter: Huaqiang Zhou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      49P - A Mendelian randomization study of the effects of Crohn’s disease on lung cancer

      12:30 - 12:30  |  Presenter: Jiaqing Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      50P - Reduced-, and no-dose thin-section radiologic examinations: Comparison of capability for nodule detection in patients having pulmonary nodules

      12:30 - 12:30  |  Presenter: Wei Tang

      • Abstract

      Loading...

    • +

      51P - Invasive diagnostic investigation-related complications and its impact on treatment initiation in lung cancer patients in a rapid access lung lesion clinic in regional Australia

      12:30 - 12:30  |  Presenter: Katherine Mccann

      • Abstract

      Loading...

    • +

      52P - Concordance, decision impact, and satisfaction for a computerized clinical decision support system in treatment of lung cancer patients

      12:30 - 12:30  |  Presenter: K. Adam Lee

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      53P - Pulmonary tuberculosis: A hurdle to overcome for early lung cancer diagnosis in TB burden countries

      12:30 - 12:30  |  Presenter: Mst Shamima Akter

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      56P - CT image standardization is superior to larger but heterogeneous data for robust radiomic models

      12:30 - 12:30  |  Presenter: Diem Vuong

      • Abstract

      Loading...

    • +

      57P - Non-small cell lung carcinoma (NSCLC) patients with baseline brain imaging: A prospective observational study

      12:30 - 12:30  |  Presenter: GUNDU NARESH

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      58P - Evaluation of a care path for patients with lung tumors and co-existing interstitial lung disease

      12:30 - 12:30  |  Presenter: Merle Ilona Ronden-Kianoush

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      59P - Comparison of internal target volume delineation using CT datasets of four-dimensional computed tomography in lung cancer radiotherapy

      12:30 - 12:30  |  Presenter: SABHEEN BUSHRA

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      60P - Nomogram for patients with stage I small cell lung cancer: A competing risk analysis

      12:30 - 12:30  |  Presenter: Jiaqing Liu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      61P - Value of post-radiotherapy for limited stage small cell lung cancer on basis of a prognostic scoring model

      12:30 - 12:30  |  Presenter: Jing Yu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      62P - External validation of a survival score for limited stage small cell lung cancer treated with chemoradiotherapy

      12:30 - 12:30  |  Presenter: Lukas Käsmann

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      63P - Real-life experience with the implementation of DLL3 staining and the subsequent treatment with rovalpituzumab tesirine in heavily pretreated SCLC patients

      12:30 - 12:30  |  Presenter: Maximilian Johannes Hochmair

      • Abstract

      Loading...

    • +

      64P - Timing of treatment with concurrent chemoradiotherapy (CRT) and impact on progression free survival (PFS) in limited stage small cell lung cancer (LSSCLC)

      12:30 - 12:30  |  Presenter: Lynda M McSorley

      • Abstract

      Loading...

    • +

      65P - Experience of prophylactic cranial irradiation in extensive stage small cell lung cancer at a regional cancer center in India

      12:30 - 12:30  |  Presenter: RANJEET RAM Jat

      • Abstract

      Loading...

    • +

      66P - Treatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practice

      12:30 - 12:30  |  Presenter: Martin Sebastian

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      67TiP - ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer

      12:30 - 12:30  |  Presenter: Suresh Senan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      73P - Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries

      12:30 - 12:30  |  Presenter: Ronald Damhuis

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      74P - Is there any prognostic significance of the level of change in SUVmax after SBRT in patients with early stage NSCLC?

      12:30 - 12:30  |  Presenter: Gokhan Yaprak

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      75P - Thoracic ultrasound can be a trustable tool in untouchable lung nodule surgery

      12:30 - 12:30  |  Presenter: Hongbin Zhang

      • Abstract

      Loading...

    • +

      76P - Endobronchial surgery and photodynamic therapy for early central lung cancer treatment

      12:30 - 12:30  |  Presenter: Sergey S Pirogov

      • Abstract

      Loading...

    • +

      77P - The prognostic impact of the international association for the study of lung cancer (IASLC) definitions on completeness of surgical resection for non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: Matteo Gagliasso

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      78P - Lung resection for cancer in patients with heart disease: Management and postoperative outcome

      12:30 - 12:30  |  Presenter: Fatmir Spiro Caushi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      79P - Tissue microarray analysis on prognostic value of coexpression of RUNX3 and trimethylated histone H3 lysine 27 in surgically resected patients with stage I non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Xiaohui Chen

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      80P - High blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: Juan Felipe Cordoba Ortega

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      81P - Higher PD-L1 expression correlates with lymphocyte infiltration in early non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Pedro Rocha

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      82TiP - IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy

      12:30 - 12:30  |  Presenter: Solange Peters

      • Abstract

      Loading...

    • +

      87P - Time-series of peripheral blood biomarkers as biomarkers for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients

      12:30 - 12:30  |  Presenter: Arsela Prelaj

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      89P - Treatment patterns and long-term survival for unresected stage III non-small cell lung cancer patients: A nationwide register study in Denmark

      12:30 - 12:30  |  Presenter: Anders Green

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      90P - Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database

      12:30 - 12:30  |  Presenter: Nicolas Girard

      • Abstract

      Loading...

    • +

      91P - Prognosis of EGFR-mutant advanced lung adenocarcinoma patients with different intrathoracic metastatic patterns

      12:30 - 12:30  |  Presenter: Fang Hu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      92P - A prospective study on the association of dose-volume histogram parameters with oesophagitis, radiation pneumonitis, radiation induced pulmonary fibrosis after receiving chemoradiation for NSCLC

      12:30 - 12:30  |  Presenter: SAIKAT Bhowal

      • Abstract

      Loading...

    • +

      93P - Heterogeneity score in inoperable stage III non-small cell lung cancer patients treated with definitive chemoradiotherapy: A single centre analysis

      12:30 - 12:30  |  Presenter: Julian Taugner

      • Abstract

      Loading...

    • +

      94P - Challenges in the management of stage III non-small cell lung cancer (NSCLC) within multidisciplinary team (MDT): A lung cancer center experience

      12:30 - 12:30  |  Presenter: Kaouther Harbegue

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      95P - The role of patient performance status and its changes before and after completion of multimodal treatment for inoperable stage III NSCLC

      12:30 - 12:30  |  Presenter: Lukas Käsmann

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      96P - Impact of thrombocytosis and neutrophil-to-lymphocyte ratio before start of chemoradiotherapy on patient survival in inoperable stage III NSCLC

      12:30 - 12:30  |  Presenter: Michael Hoffmann

      • Abstract

      Loading...

    • +

      97P - Pattern of first-site failure and salvage treatment in patients with inoperable stage III non-small cell lung cancer after chemoradiotherapy

      12:30 - 12:30  |  Presenter: Chukwuka Eze

      • Abstract

      Loading...

    • +

      98P - Implications for UK practice of the use of durvalumab in stage III NSCLC

      12:30 - 12:30  |  Presenter: Muhammad Shahid Iqbal

      • Abstract

      Loading...

    • +

      99P - Efficacy and safety of adjuvant chemotherapy in lung cancer: Real-world evidence

      12:30 - 12:30  |  Presenter: Felipe Santa Rosa Roitberg

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      100P - A new PET-CT score for locally-advanced inoperable NSCLC stage III patients treated with chemoradiotherapy

      12:30 - 12:30  |  Presenter: Olarn Roengvoraphoj

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      101TiP - PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy

      12:30 - 12:30  |  Presenter: Nicolas Girard

      • Abstract

      Loading...

    • +

      121P - Risk of not receiving second-line therapy is high in EGFR mt+ patients: Real-world data of certified lung cancer centers on treatment sequence in EGFR mt+ patients

      12:30 - 12:30  |  Presenter: Julia Roeper

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      122P - Osimertinib as first-line (1L) treatment for epidermal growth factor receptor (EGFR) mutation-positive advanced non-small cell lung cancer (NSCLC): Final efficacy and safety results from two phase I expansion cohorts

      12:30 - 12:30  |  Presenter: James Chih-Hsin Yang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      123P - Long term survival analysis of osimertinib in stage IV NSCLC patients harbored acquired EGFR T790M mutation: A real-word study in China

      12:30 - 12:30  |  Presenter: Shuyuan Wang

      • Abstract

      Loading...

    • +

      124P - The effect of proton pump inhibitors (PPI) on dacomitinib (DACO) pharmacokinetics and efficacy in non-small cell lung cancer (NSCLC) patients with activating epidermal growth factor receptor (EGFR) mutation

      12:30 - 12:30  |  Presenter: Jerry Li

      • Abstract

      Loading...

    • +

      125P - Elderly patients treated with afatinib in clinical practice: Results from the prospective non-interventional study GIDEON

      12:30 - 12:30  |  Presenter: Wolfgang Brückl

      • Abstract

      Loading...

    • +

      126P - Regional retrospective analysis of outcomes of EGFR mutated non-squamous non-small cell lung cancer (NSCLC) patients in West Yorkshire

      12:30 - 12:30  |  Presenter: Darshan Sharma

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      127P - Obesity has an impact on the efficacy of EGFR-TKI in NSCLC patients harbouring EGFR mutation: A real-world study

      12:30 - 12:30  |  Presenter: Zhen-Yu Ding

      • Abstract

      Loading...

    • +

      128P - Frequency and types of EGFR mutation in Moroccan patients with non-small cell lung cancer

      12:30 - 12:30  |  Presenter: mohamed lemine sow

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      129P - Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Zengzhi Lian

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      130P - Relationship of clinicopathological characteristics, EGFR genotyping and prognosis in non-small cell lung cancer patients with malignant pleural effusion

      12:30 - 12:30  |  Presenter: Jing Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      131P - Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma

      12:30 - 12:30  |  Presenter: Changhui Li

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      132P - New insights into acquired resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor therapy in lung cancer

      12:30 - 12:30  |  Presenter: Jana Fassunke

      • Abstract

      Loading...

    • +

      133P - A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant

      12:30 - 12:30  |  Presenter: Jingjing Qu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      134P - Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors

      12:30 - 12:30  |  Presenter: Svenja Wagener

      • Abstract

      Loading...

    • +

      135P - EGFR & PD L1: An (im)perfect union

      12:30 - 12:30  |  Presenter: Ullas Batra

      • Abstract

      Loading...

    • +

      136P - Correlation of molecular status and anatomic sites of metastases at diagnosis of EGFR positive non-small cell lung cancer (NSCLC): A single institution experience

      12:30 - 12:30  |  Presenter: Kristina Krpina

      • Abstract

      Loading...

    • +

      137P - Detection and clinicopathologic features of ctDNA in T790M-positive advanced lung adenocarcinomas patients after failure of treatment with first- and second-generation EGFR-TKIs

      12:30 - 12:30  |  Presenter: wei he

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      138P - PD-L1 confers primary resistance to EGFR-TKI in EGFR mutant non-small cell lung cancer via inducing EMT phenotype

      12:30 - 12:30  |  Presenter: Yang Zhang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      139P - Real-world immuno-oncology (IO) therapy treatment patterns and outcomes in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) in the United States

      12:30 - 12:30  |  Presenter: Xiaoyun Pan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      140P - Brigatinib experience on the ALK project

      12:30 - 12:30  |  Presenter: Fabio Gomes

      • Abstract

      Loading...

    • +

      141P - Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)

      12:30 - 12:30  |  Presenter: Laura Angelats

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      142P - Clinical management of advanced lung adenocarcinoma with ALK rearrangement: Real-world treatment outcomes and long-term survival

      12:30 - 12:30  |  Presenter: Bo Zhang

      • Abstract

      Loading...

    • +

      143P - Role of radiotherapy in management of brain metastases in anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC): A single-center retrospective study

      12:30 - 12:30  |  Presenter: Yiming Zhao

      • Abstract

      Loading...

    • +

      144P - Clinical and treatment features associated with improved 5-year survival rate in ALK-positive lung cancer treated with ALK-TKIs

      12:30 - 12:30  |  Presenter: Antonio Passaro

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      145P - Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients

      12:30 - 12:30  |  Presenter: Cleon Kho

      • Abstract

      Loading...

    • +

      146P - Clinical significance of ROS1 5’ deletions detected by FISH and response to crizotinib

      12:30 - 12:30  |  Presenter: Filippo Gustavo Dall'Olio

      • Abstract

      Loading...

    • +

      147P - Impact on KRAS-subtypes and TP53 mutations on the prognostic value of KRAS/KEAP1 comutations in non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: Matthias Scheffler

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      148P - KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic non-squamous NSCLC

      12:30 - 12:30  |  Presenter: Marika Cinausero

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      149P - Efficacy of tyrosine kinase inhibitors (TKIs) in advanced lung adenosquamous carcinoma

      12:30 - 12:30  |  Presenter: Minjuan Hu

      • Abstract

      Loading...

    • +

      150P - Characterization of patients with metastatic non-small cell lung cancer obtaining long term benefit from immunotherapy

      12:30 - 12:30  |  Presenter: Giulia Galli

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      151P - Safety and tolerability of pembrolizumab or placebo plus pemetrexed and platinum as first-line therapy in Japanese patients (PTS) with metastatic non-squamous non-small cell lung cancer (NSCLC) enrolled in the phase III KEYNOTE-189 study

      12:30 - 12:30  |  Presenter: Hidehito Horinouchi

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      152P - Correlation among different KRAS alterations, genetic co-mutations and PD-L1 expression in patients treated with immunotherapy in metastatic NSCLC

      12:30 - 12:30  |  Presenter: Letizia Gianoncelli

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      153P - Chemotherapy with immune-checkpoint inhibitors in first-line treatment metastatic NSCLC patients: Systematic review and literature-based meta-analysis

      12:30 - 12:30  |  Presenter: Alfredo Addeo

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      154P - Renal toxicity from platinum/pemetrexed and pembrolizumab in the era of combination therapy

      12:30 - 12:30  |  Presenter: Daphne Dumoulin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      155P - Association of immune-related adverse events (irAEs) and immunotherapy (IT) benefit in advanced non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: Cristina Saavedra Serrano

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      156P - Peripheral blood biomarkers as prognostic factors for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients

      12:30 - 12:30  |  Presenter: Arsela Prelaj

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      157P - Prognostic impact of the use of antibiotics in patients with advanced non-small cell lung cancer (NSCLC) receiving PD-(L)1 targeting monoclonal antibodies

      12:30 - 12:30  |  Presenter: Anne Schett

      • Abstract

      Loading...

    • +

      158P - Immune-related adverse events (irAEs) in advanced non-small cell lung cancer (aNSCLC): Platelet-to-lymphocyte ratio (PLR) predicts the risk of development and relapse

      12:30 - 12:30  |  Presenter: Alberto Pavan

      • Abstract

      Loading...

    • +

      159P - Initial serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC

      12:30 - 12:30  |  Presenter: David Lang

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      160P - EPSILoN score: Validation cohort of a prognostic score in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy

      12:30 - 12:30  |  Presenter: Arsela Prelaj

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      161P - Tumor mutational burden assessed by a targeted NGS assay predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Philip Jermann

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      162P - Monitoring of blood serum amyloid (SAA) to predict outcome of first-line pembrolizumab (P) in patients (pts) with advanced non-small cell lung cancer (ANSCLC)

      12:30 - 12:30  |  Presenter: Vincenzo Pio Di Noia

      • Abstract

      Loading...

    • +

      163P - Immuno-oncological treatment and tumor load in non-small cell lung cancer (NSCLC): Case-control analysis of overall survival (OS) in routine clinical practice

      12:30 - 12:30  |  Presenter: Martin Faehling

      • Abstract

      Loading...

    • +

      164P - PD-L1 expression affect the efficacy of pemetrexed maintenance therapy in real-world patients with advanced non-squamous NSCLC

      12:30 - 12:30  |  Presenter: Yi Qin

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      165P - Clinical benefit of anti PD-1/PD-L1 plus chemotherapy versus chemotherapy alone in first-line treatment in advanced non-small cell lung cancer: A meta-analysis

      12:30 - 12:30  |  Presenter: Thierry Landre

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      166P - Correlation of various clinical, imaging and laboratory parameters with outcome in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs): Results from a prospective, observational, single institution study

      12:30 - 12:30  |  Presenter: Konstantinos Rounis

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      167P - Prognostic significance of neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Bernardo L. Rapoport

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      168P - Dynamic changes of patelet-to-lymphocyte ratio predict efficacy of PD-1/PD-L1 inhibitors in NSCLC

      12:30 - 12:30  |  Presenter: Fei Zhou

      • Abstract

      Loading...

    • +

      169P_PR - Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP)

      12:30 - 12:30  |  Presenter: Elena Corral de la Fuente

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      170P - Advanced non-small cell lung cancer patients with low tumor mutation burden might derive benefit from anti-programmed cell death (PD)-1 and anti-programmed deathligand 1 (PD-L1) blockade

      12:30 - 12:30  |  Presenter: Wei Nie

      • Abstract

      Loading...

    • +

      171P - Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC

      12:30 - 12:30  |  Presenter: Fei Zhou

      • Abstract

      Loading...

    • +

      172P - A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer

      12:30 - 12:30  |  Presenter: Baohui Han

      • Abstract

      Loading...

    • +

      173P - Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival

      12:30 - 12:30  |  Presenter: Stephanie G.C. Kroeze

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      174P - NSCLC stages IIa-IIIc: Tumor related IGRT yields better local control than kV-guidance to anatomic structures

      12:30 - 12:30  |  Presenter: Franz Zehentmayr

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      175P - Permanent pleural catheter (PPC) for malignant pleural effusion (PE) in advanced non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: MIREIA Martinez Kareaga

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      176P - Real-world treatment patterns for metastatic non-small cell lung cancer at IRST Italy

      12:30 - 12:30  |  Presenter: Mattia Altini

      • Abstract

      Loading...

    • +

      177P - Real-world experience of ALK positive NSCLC from India

      12:30 - 12:30  |  Presenter: Mridul Malhotra

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      178P - Feasibility of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET for treatment monitoring of brain metastases in lung cancer patients

      12:30 - 12:30  |  Presenter: Diana SY Abdulla

      • Abstract

      Loading...

    • +

      179P - Treatment (tx) characteristics of patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC) receiving atezolizumab (atezo) monotherapy in US clinical practice

      12:30 - 12:30  |  Presenter: Martin Frueh

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      180TiP - An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer

      12:30 - 12:30  |  Presenter: James Spicer

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      181TiP - Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study

      12:30 - 12:30  |  Presenter: Motostugu Shimokawa

      • Abstract

      Loading...

    • +

      182TiP - A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study

      12:30 - 12:30  |  Presenter: Paul K. Paik

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      183TiP - A phase II study of [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-overexpressing or -mutated advanced non-small cell lung cancer

      12:30 - 12:30  |  Presenter: David Planchard

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      184TiP - FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered squamous NSCLC

      12:30 - 12:30  |  Presenter: Lucia Nogova

      • Abstract

      Loading...

    • +

      185TiP - RATIONALE 001: Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: Luis Paz-Ares

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      186TiP - An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy: EDEN trial

      12:30 - 12:30  |  Presenter: Francesco Gelsomino

      • Abstract

      Loading...

    • +

      187TiP - Tumor treating fields concurrent with standard of care therapy for stage IV NSCLC following platinum failure: Phase III LUNAR study

      12:30 - 12:30  |  Presenter: Uri Weinberg

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      188TiP - Metformin +/- cyclic fasting mimicking diet in combination with platinum-pemetrexed chemotherapy for advanced LKB1 inactive lung adenocarcinoma: The FAME trial

      12:30 - 12:30  |  Presenter: Giulia Galli

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      190P - ERGR-TKIs combined with chemotherapy delays intracranial progression in EGFR-mutant lung adenocarcinoma patients

      12:30 - 12:30  |  Presenter: Changhui Li

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      191P - Assessment of toxicity and clinical outcomes with SBRT in lung metastases: A single institute experience

      12:30 - 12:30  |  Presenter: Vibhay Pareek

      • Abstract

      Loading...

    • +

      192P - Characterization and potential role of PD-L1 positive lung cancer stem cells in lymph nodes metastasis

      12:30 - 12:30  |  Presenter: Agata Raniszewska

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      193P - Management of cN2 NSCLC patients treated with radical radiotherapy: Relapse with or without brain metastases

      12:30 - 12:30  |  Presenter: Fiona McKay

      • Abstract

      Loading...

    • +

      195TiP - Phase III METIS study: Tumor treating fields (150 kHz) and radiosurgery for supra- and/or infratentorial brain metastases (1-10) from non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: Minesh Mehta

      • Abstract

      Loading...

    • +

      197P - Effect of surgical treatment on the survival in patients with malignant pleural mesothelioma

      12:30 - 12:30  |  Presenter: Renata Baez-Saldana

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      198P - Efficacy of 150 kHz tumor treating fields (TTFields) and cisplatin or pemetrexed for the treatment of mesothelioma cells in vitro

      12:30 - 12:30  |  Presenter: Uri Weinberg

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      199P - Safety meta-analysis of clinical trials delivering TTFields to the upper torso

      12:30 - 12:30  |  Presenter: Giovanni Luca Ceresoli

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      200P - Implementation of artificial intelligence (AI) for lung cancer clinical trial matching in a tertiary cancer center

      12:30 - 12:30  |  Presenter: Konstantinos Leventakos

      • Abstract

      Loading...

    • +

      201P - Psychosocial and financial impact on family of lung cancer patients: A cancer research center experience

      12:30 - 12:30  |  Presenter: SANJAY KUMAR GODARA

      • Abstract

      Loading...

    • +

      202P - Information for lung cancer patients and their caregivers: A systematic analysis of the online landscape

      12:30 - 12:30  |  Presenter: Paul Naish

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      203P - Retrospective study about lung carcinoid: Our experience in a Spanish hospital

      12:30 - 12:30  |  Presenter: Dario SANCHEZ Sanchez Cabrero

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      204P - Diagnostic value of concomitant use of radial probe endobronchial ultrasound with guide sheath and transbronchial biopsy in lung cancer

      12:30 - 12:30  |  Presenter: Sang Chul Lee

      • Abstract

      Loading...

    • +

      205P - Non-small cell lung cancer in the elderly: A retrospective study comparing first-line treatment with single-agent vs combination chemotherapy vs tyrosine kinase inhibitor

      12:30 - 12:30  |  Presenter: Élia Cipriano

      • Abstract

      Loading...

    • +

      206P - Implementation of PD-L1 analysis among patients with non-small cell lung cancer in a single center

      12:30 - 12:30  |  Presenter: IOANNA TSIOUPROU

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      207P - Primary mucinous carcinomas of the lung: Clinical characteristics and treatment outcomes

      12:30 - 12:30  |  Presenter: Antony George Francis Thottian

      • Abstract

      Loading...

    • +

      208P - Sarcopenia as prognostic factor in lung cancer patients: A systematic review and meta-analysis

      12:30 - 12:30  |  Presenter: Judith Büntzel

      • Abstract

      Loading...

    • +

      209P - Feasibility and utility of transbronchial cryobiopsy in primary lung cancer: Prospective, single arm study

      12:30 - 12:30  |  Presenter: Keisuke Kirita

      • Abstract

      Loading...

    • +

      210TiP - Evaluation of safety and efficacy of minocycline combined with tyrosine kinase inhibitors in patients of EGFR mutated metastatic lung cancer

      12:30 - 12:30  |  Presenter: Antony George Francis Thottian

      • Abstract

      Loading...

  • +

    MSD - Industry Satellite Symposium

    • Type: Industry Satellite symposium
    • Presentations: 5
    • Coordinates: 4/11/2019, 13:00 - 14:00, Room A
    • +

      Welcome and introduction

      13:00 - 13:05  |  Presenter: Natasha Leighl

      • Abstract

      Abstract not provided

    • +

      IO combinations in first-line NSCLC

      13:05 - 13:20  |  Presenter: Delvys Rodríguez-Abreu

      • Abstract

      Abstract not provided

    • +

      Role of monotherapy in first-line NSCLC

      13:20 - 13:35  |  Presenter: Natasha Leighl

      • Abstract

      Abstract not provided

    • +

      Patient profiles/cases

      13:35 - 13:50  |  Presenter: Stephen V Liu

      • Abstract

      Abstract not provided

    • +

      Q&A and Closing Remarks

      13:50 - 14:00  |  Presenter: Natasha Leighl

      • Abstract

      Abstract not provided

  • +

    Microbiome in cancer immunotherapy

    • Type: Keynote Lecture
    • Presentations: 2
    • Coordinates: 4/11/2019, 14:10 - 14:40, Room B
  • +

    ESMO-IASLC Best Abstracts

    • Type: Proffered Paper session
    • Presentations: 7
    • Coordinates: 4/11/2019, 14:45 - 16:15, Room B
    • +

      Session DOI

      14:45 - 14:45

      • Abstract

      Abstract not provided

    • +

      LBA1_PR - Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

      14:45 - 15:00  |  Presenter: Taofeek K Owonikoko

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      LBA3 - Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC

      15:00 - 15:15  |  Presenter: Byoung Chul Cho

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Invited Discussant LBA1_PR and LBA3

      15:15 - 15:30  |  Presenter: Luis Paz-Ares

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      102O - Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

      15:30 - 15:45  |  Presenter: Tony S.K. Mok

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      103O_PR - Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042

      15:45 - 16:00  |  Presenter: Kaname Nosaki

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Invited Discussant 102O and 103O_PR

      16:00 - 16:15  |  Presenter: Sanjay Popat

      • Abstract
      • Presentation
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Management of side effects and toxicities

    • Type: Educational session
    • Presentations: 6
    • Coordinates: 4/11/2019, 14:45 - 16:15, Room A
  • +

    SCLC: What are the challenges and how can we face them?

    • Type: Educational session
    • Presentations: 6
    • Coordinates: 4/11/2019, 14:45 - 16:15, Room C
    • +

      Session DOI

      14:45 - 14:45

      • Abstract

      Abstract not provided

    • +

      The pathologist’s point of view